Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 2 Rising Biotechs That Could Become the Next Novo Nordisk
2 Rising Biotechs That Could Become the Next Novo Nordisk
2 Rising Biotechs That Could Become the Next Novo Nordisk
Submitted by
admin
on January 29, 2024 - 11:04am
Source:
Motley Fool
News Tags:
Novo Nordisk
Madrigal Pharmaceuticals
Viking Therapeutics
NASH
Headline:
2 Rising Biotechs That Could Become the Next Novo Nordisk
snippet:
Novo Nordisk has been a great investment due to its drugs for diabetes and obesity.
Madrigal Pharmaceuticals has big plans for treating a serious liver disease known as NASH.
Viking Therapeutics is also focused on NASH, and it has plenty of cash on hand.
Do Not Allow Advertisers to Use My Personal information
